Asceneuron S.A.: Clinical Trials

1 trial sponsored by Asceneuron S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Asceneuron S.A.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ASN51 in Adults With Early Alzheimer's Disease
ASN51, Placebo - Alzheimer Disease
Phase 2TerminatedAsceneuron S.A.1232024-10-162025-06-29

Conditions studied

Alzheimer Disease (1)

Countries

United States (1)